Status:
COMPLETED
Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Cyclic Vomiting Syndrome
Eligibility:
All Genders
Up to 17 years
Brief Summary
The main purpose of this study is the comparison of frequency of vomiting episodes (number of episodes per year) observed during the year after the begin of Q10 coenzyme treatment to frequency observe...
Eligibility Criteria
Inclusion
- Cyclic vomiting syndrome as defined by Rome IV criteria
- Treated with Q10 coenzyme treatment for cyclic vomiting syndrome
- Q10 coenzyme treatment started between January 2000 and July 2006
Exclusion
- \- Refusal of processing of personal data reported in patient medical files
Key Trial Info
Start Date :
December 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2017
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03295760
Start Date
December 1 2016
End Date
July 31 2017
Last Update
September 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital - CHRU de Nancy
Vandœuvre-lès-Nancy, France